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;Rbpj ⌬/⌬ ) or not (Dmp1-Cre ϩ/Ϫ ;Rosa Notch ) of Rbpj inactivation. Dmp1-Cre ϩ/Ϫ ;Rosa Notch mice exhibited increased femoral trabecular bone volume and decreased osteoclasts and bone resorption. The phenotype was reversed in the context of the Rbpj inactivation, demonstrating that Notch canonical signaling was accountable for the phenotype. Notch activation downregulated Sost and Dkk1 and upregulated Axin2, Tnfrsf11b, and Tnfsf11 mRNA expression, and these effects were not observed in the context of the Rbpj inactivation. In conclusion, Notch activation in osteocytes suppresses bone resorption and increases bone volume by utilization of canonical signals that also result in the inhibition of Sost and Dkk1 and upregulation of Wnt signaling. Notch; Rbpj; Sost; osteocytes; bone remodeling BONE REMODELING IS A COORDINATED PROCESS dependent on the activity of bone-forming osteoblasts, bone-resorbing osteoclasts, and osteocytes (7, 40, 44) . Osteocytes are osteoblasts that become embedded in the bone matrix, acquiring a dendritic morphology in specialized lacunae and distinct functions (11) . Through a canalicular network, osteocytes communicate their signals to other skeletal cells in the bone microenvironment. Osteocytes play a fundamental role in bone remodeling and mechanotransduction and respond to mechanical loading by converting extracellular forces into intracellular signals that regulate specific pathways (27, 35, 52, 55) .
Notch (1 to 4) are single-pass transmembrane receptors that play a critical role in cell fate decisions (58, 59) . Notch regulates skeletal development and homeostasis and osteoblast and osteoclast differentiation (17, 23, 62) . Notch is activated by Notch-ligand interactions, resulting in the release of the Notch intracellular domain (NICD). In the canonical signaling pathway, NICD translocates to the nucleus, displacing transcriptional repressors and interacting with recombination signal binding protein for immunoglobulin J region (Rbpj) and with Mastermind-like (Maml) proteins to regulate transcription (29, 36, 54) . Classic targets of Notch canonical signaling include hairy enhancer of split (Hes)1, -5, and -7 and Hes related with YRPW motif (Hey)1, -2, and -L (24, 25, 34) .
Studies on the activation of Notch1 and on the inactivation of Notch1 and Notch2 in cells of the osteoblastic lineage at various stages of differentiation reveal an inhibitory role of Notch in osteoblastogenesis (8, 57) . Inactivation of Notch1 and Notch2 in the developing skeleton causes a transient increase in trabecular bone volume due to increased osteoblast number/ function followed by osteopenia, due to an increase in osteoclastogenesis and bone resorption (23) . These and related findings suggest that Notch1 has the potential to inhibit both osteoblast and osteoclast differentiation (2, 13, 61) .
Recently, we explored the effects of Notch1 activation in cells of the osteoblastic lineage at various stages of cell differentiation and confirmed that activation of Notch1 impairs osteoblast differentiation/function (8) . In contrast, Notch1 activation in osteocytes had distinct effects causing a pronounced increase in cancellous bone due to a suppression of bone resorption and an increase of cortical bone formation (6, 8) . The mechanism of action of Notch in osteocytes included suppression of Sost expression and consequently enhanced Wnt signaling. Notch also induced Tnfrsf11b, encoding for osteoprotegerin, either directly or through the enhancement of Wnt activity (5) .
The intent of the present study was to explore pathways responsible for the actions of Notch in osteocytes and determine whether Notch canonical signaling (Rbpj dependent) had a function in osteocytes and was responsible for the effects of Notch activation in these cells. To determine whether Rbpj had a function in osteocytes under basal conditions, Rbpj conditional mice were crossed with transgenic mice expressing the Cre recombinase under the control of the dentin matrix protein-1 (Dmp1) promoter (Dmp1-Cre). To activate Notch1 preferentially in osteocytes, Rosa Notch mice, where a loxPflanked STOP cassette was cloned downstream of the Rosa26 promoter and upstream of the coding sequence of the Notch1 NICD, were crossed with Dmp1-Cre transgenic mice (31, 33 
MATERIALS AND METHODS
Rosa
Notch mice. Rosa Notch mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and studied in a C57BL/6 genetic background (33, 47) . In these mice, the Rosa26 locus is targeted with a DNA construct encoding the Notch1 NICD, preceded by a STOP cassette flanked by loxP sites, cloned downstream of the Rosa26 promoter, so that NICD is expressed following the excision of the STOP cassette by Cre recombination (4, 43 Microcomputed tomography. Bone microarchitecture of femurs from experimental and control mice was determined using a microcomputed tomography instrument (CT 40; Scanco Medical, Bassersdorf, Switzerland), which was calibrated weekly using a phantom provided by the manufacturer (3, 20) . Femurs were scanned in 70% ethanol at high resolution, energy level of 55 peak kV, intensity of 145 A, and integration time of 200 ms. Trabecular bone volume fraction and microarchitecture were evaluated starting 1.0 mm proximal from the femoral condyles. A total of 160 consecutive slices were acquired at an isotropic voxel dimension of 216 m 3 and a slice thickness of 6 m and chosen for analysis. Contours were manually drawn every 10 slices a few voxels away from the endocortical boundary to define the region of interest for analysis. The remaining slice contours were iterated automatically. Trabecular regions were assessed for total volume, bone volume, bone volume fraction (bone volume/total volume, BV/TV), trabecular thickness (Tb.Th), number (Tb.N), and separation, connectivity density (Conn.D), and structure model index (SMI), using a Gaussian filter ( ϭ 0.8) and user-defined thresholds (3, 20) . For analysis of femoral cortical bone, contours were iterated across 100 slices along the cortical shell of the femoral midshaft, excluding the marrow cavity. Analyses of bone volume/total volume (BV/TV), porosity, cortical thickness, cross-sectional tissue (TA) and bone (BA) areas, periosteal (P.peri) and endocortical (P.endo) perimeters, and material density were performed using a Gaussian filter ( ϭ 0.8) and user-defined thresholds. The terminology and units used are in accordance with guidelines published by the Journal of Bone and Mineral Research (3) . Bone histomorphometric analysis. Static and dynamic histomorphometry were carried out on mice injected with calcein (20 mg/kg) and demeclocycline (50 mg/kg) at an interval of 2 days in 1-mo-old or of 7 days in 3-mo-old animals. Five-micrometer longitudinal sections of femurs and cross sections at the middiaphysis were cut on a microtome (Microm; Richards-Allan Scientific, Kalamazoo, MI) and stained with 0.1% toluidine blue. Static parameters of cancellous bone Table 2 
. Primers used for qRT-PCR determinations
GenBank accession number identifies transcript recognized by primer pairs. histomorphometry were measured in a defined area between 360 and 2,160 m from the growth plate, using an OsteoMeasure morphometry system (Osteometrics, Atlanta, GA). Bone area/tissue area (BA/ TA) is expressed as percent trabecular bone over the defined tissue area measured, and trabecular number (Tb.N) as number of trabeculae/mm; osteoblast (NOb/BPm) and osteoclast (NOc/BPm) number per bone perimeter are expressed as the number of cells per millimeter of trabecular perimeter; osteoblast (ObS/BS), osteoclast (OcS/BS), and eroded (ES/BS) bone surfaces are expressed as percentage of the traced bone surface occupied by osteoblasts, osteoclasts, or resorbed surface, respectively. For dynamic histomorphometry, fluorescent labels were visualized on unstained sections under ultraviolet light, using a triple diamidino-2-phenylindole/fluorescein/Texas red set long-pass filter. Osteoclast number/endocortical perimeter was measured in cross sections at middiaphysis and expressed as osteoclasts per millimeter of endocortical surface. The terminology and units used are those recommended by the Histomorphometry Nomenclature Committee of the American Society for Bone and Mineral Research (12, 41) .
qRT-PCR. Total RNA was extracted from calvariae or tibiae of 1-mo-old control and experimental mice of both sexes, and mRNA levels were determined by qRT-PCR (37, 38) . For this purpose, equal amounts of RNA were reverse-transcribed using the iScript RT-PCR kit (Bio-Rad), according to the manufacturer's instructions and amplified in the presence of specific primers (Table 2 ) and iQ SYBR Green Supermix (Bio-Rad) at 60°C for 35 cycles. Transcript copy number was estimated by comparison with a serial dilution of cDNA for Axin2 (GE Healthcare Dharmacon, Lafayette, CO) Dkk1 (encoding for Dickkopf-related protein-1, from C. Niehrs, Heidelberg, Germany), Hey1, Hey2 (both from T. Iso (Fig. 1) . The appearance of Rbpj conditional null mice and their weight and femoral length were not different from controls (Fig. 1) . CT of the distal femur revealed that male and female 1-and 3-mo-old Dmp1-Cre ϩ/Ϫ ;Rbpj ⌬/⌬ mice did not have an obvious phenotype in either trabecular or cortical bone compared with littermate Rbpj loxP/loxP mice (Tables 3 and 4 ). Minor differences in selected parameters of the CT analysis were noted, but overall, Dmp1-Cre ϩ/Ϫ ;Rbpj ⌬/⌬ mice were not different from controls, indicating that Rbpj is dispensable in osteocytes.
Rescue of Dmp1-Cre ϩ/Ϫ ;Rosa Notch skeletal phenotype by Rbpj inactivation. The skeletal phenotype of Dmp1-Cre ϩ/Ϫ ; Rosa Notch mice expressing the Notch1 NICD preferentially in osteocytes was described in previous reports from this laboratory (6, 8) . To determine whether the phenotype was secondary to activation of Notch canonical signaling, Dmp1-Cre ϩ/Ϫ ; Rosa Notch mice were studied in the context (Dmp1-Cre ϩ/Ϫ ; Rosa Notch ;Rbpj ⌬/⌬ ) or not of Rbpj inactivation. Cre-mediated recombination of Rbpj loxP sequences was documented in tibiae from Rbpj deleted mice of both sexes (Fig. 2) . Preferential activation of Notch in osteocytes resulted in a decrease in weight and femoral length in female but not in male mice, and the effect was reversed in the context of the Rbpj inactivation (Fig. 2 ). In agreement with former studies, femoral CT revealed that 1-mo-old male Dmp1-Cre ϩ/Ϫ ;Rosa Notch mice had a marked increase in trabecular bone volume/tissue volume compared with Rosa Notch controls because of an increase in trabecular number (Fig. 3) (6) . Cortical total and bone area were increased, but bone was porous, so that cortical bone volume/total volume was decreased in Dmp1-Cre ϩ/Ϫ ;Rosa Notch mice. The effects of Notch in osteocytes were secondary to activation of the canonical pathway since they were reversed in the context of the Rbpj inactivation, and skeletal microarchitecture parameters of Dmp1-Cre ϩ/Ϫ ;Rosa
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;Rbpj ⌬/⌬ mice were not different from control Rosa Notch mice except for a slight increase in connectivity density (Fig. 3) . A similar phenotype of the Notch activation in osteocytes was observed in female mice, and the phenotype also was reversed in the context of the Rbpj inactivation (Fig. 4) . Bone histomorphometric analysis confirmed the increase in cancellous bone in Dmp1-Cre ϩ/Ϫ ; Rosa Notch mice due to a decrease in osteoclast number and eroded surface with no changes in osteoblast number in male (Fig. 5) and female (Fig. 6) mice. The animals studied by CT and histomorphometry overlapped by 30% for male and 70 -75% for female mouse cohorts. Changes in osteoclast number appeared limited to cancellous bone, since number of oste- (Figs. 5 and 6 ). Calcein and demeclocycline labels were detected only in a limited number of mice, such that dynamic histomorphometry parameters could not be established.
Mechanisms responsible for the effect of Notch in osteocytes.
In previous work, we demonstrated that the preferential activation of Notch in osteocytes caused a marked suppression of Sost and, to a lesser extent, Dkk1, genes encoding for the Wnt antagonists sclerostin and dickkopf1 (6) . As a consequence, there was an increase in Wnt signaling. To determine whether these effects, as well as the upregulation of Tnfrsf11b (encoding for osteoprotegerin), were mediated by Notch canonical signaling, calvariae and tibiae extracts were obtained from Dmp1-Cre ϩ/Ϫ
;Rosa
Notch mice in the context or not of the Rbpj inactivation. The preferential activation of Notch in osteocytes resulted in an induction of the Notch target genes Hey1, Hey2, and HeyL, and the induction of Tnfrsf11b and Tnfsf11 and suppression of Sost and Dkk1 with a consequent increase in Axin2 mRNA in calvariae (Fig. 7) and tibiae (Fig. 8) ; the suppression of Dkk1 reached statistical significance only in calvariae. In the context of Notch activation in osteocytes, deletion of Rbpj reversed the stimulatory effect of Notch on Hey1, Hey2, HeyL, Tnfrsf11b, and Tnfsf11 transcripts, and the inhibition of Sost and stimulation of Axin2 mRNA levels in calvariae (Fig. 7) . The same trend was observed in mRNA levels obtained in tibiae (Fig. 8) suppression of Sost and Dkk1 and to some extent that of the induction of Tnfrsf11b may explain the reversal of the Notch phenotype by the downregulation of Rbpj.
DISCUSSION
Osteocytes are cells embedded in the bone matrix and communicate through a canalicular network with each other and with osteoblasts and lining cells. Osteocytes play a fundamental role in mechanotransduction, and osteocyte-ablated mice exhibit bone loss and microstructural deterioration (49) . Osteocytes and osteoblasts do not have redundant functions, and the impact of a regulatory signal may result in different biological events when it operates in osteoblasts or when it is activated in osteocytes. Whereas Notch activation in immature and mature osteoblasts causes osteopenia, its preferential activation in osteocytes causes osteopetrosis (8) . This is because the effects of Notch are cell context dependent.
Although the effects of Notch in cancellous bone are not sexually dimorphic, Notch activation in osteocytes resulted in lower weight and shorter femurs in female but not in male Dmp1-Cre ϩ/Ϫ ;Rosa Notch mice (8) . There is no clear explanation for this difference, which is observed as early as 1 mo of age, suggesting independence from hormonal influences. This does not discount potential sex hormone-Notch interactions in adult mice. Since ovariectomy enhances bone resorption and Notch activation in osteocytes suppresses this process, it is possible for estrogen deficiency to oppose the Notch phenotype. Conversely, Notch activation in osteocytes may serve to protect from the bone loss of estrogen deficiency. Our findings confirm that the activation of Notch1 canonical signaling preferentially in osteocytes causes an increase in cancellous bone volume. This osteopetrotic phenotype can be explained by an induction of osteoprotegerin, and a suppression of Sost and Dkk1 leading to enhanced Wnt signaling and an inhibition of bone resorption. It is of interest to note that Notch activation in osteoblasts and ST-2 stromal cell lines inhibits Wnt signaling directly, explaining the osteopenic phenotype observed following the activation of Notch in osteoblasts (13, 62) . Since the expression of Sost in osteoblasts is minimal, it cannot be downregulated by Notch so that Wnt signaling cannot be enhanced by this mechanism in osteoblasts, as it can in osteocytes. The downregulation of Wnt antagonists by Notch with the consequent increase in Wnt signaling may serve as a positive feedback autocrine regulatory mechanism, since Wnt itself can activate the Notch pathway in osteocytes (51) .
Wnt signaling induces osteoblastogenesis and inhibits osteoclastogenesis and bone resorption, and the constitutive activation of ␤-catenin in the osteoblast and osteoclast lineages causes osteopetrosis (5, 19, 32, 53) . The inhibitory effect of Wnt signaling on bone resorption resembles the effect of the Notch activation in osteocytes and has been explained by an increase in osteoprotegerin expression by cells of the osteoblastic lineage and by direct effects of Wnt on osteoclast precursors (1, 9, 42) . Increases in bone volume are reported in conditions where suppressed bone resorption and decreased remodeling are the dominant events, such as the inactivation of Tnfrsf11a, encoding for the receptor activator of NF-B (Rank) and the transgenic overexpression of Tnfrsf11b (encoding for osteoprotegerin) (16, 30, 39, 46) . Although Notch activation in osteocytes causes a cancellous bone osteopetrotic phenotype, the cortical bone remains porous. This appearance resembles murine cortical bone during embryonic development and may represent failure to form a fully mature and compact cortical bone under conditions of Notch activation (45) . The cortical bone phenotype is more apparent when Notch is activated in osteocalcin-expressing cells; and under these conditions cortical bone fails to form as a compact structure (8) . Examination of von Kossa-stained histological sections does not suggest a failure to mineralize but to form a compact cortex (E. Canalis, unpublished observations). Moreover, the cortical porosity could not be attributed to an increased number of osteoclasts on cortical bone, since osteoclast number in the endocortical surface did not differ between Dmp1-Cre ϩ/Ϫ ; Rosa Notch and control mice. The suppression of bone resorption by Notch1 activation in osteocytes is in accord with the previously reported inhibitory effect of Notch on osteoclastogenesis. Notch1 inhibits osteoclastogenesis by direct effects on osteoclast precursors and indirectly through actions in cells of the osteoblastic lineage by altering the osteoprotegerin/Rankl ratio (2). However, in former (6) and in the present studies, we did not detect differences in the osteoprotegerin/Rankl ratio at the mRNA level between Notchactivated and control mice. It is important to note that other Notch receptors may have distinct effects on the skeleton, and activation of Notch2 in cells of the osteoclast lineage causes an induction of nuclear factor of activated T cells (Nfat)c1 and enhanced osteoclastogenesis (18) . It is of interest that this effect is accompanied by an increase in the expression of the Notch target gene Hes1, and Hes1 expression in skeletal cells causes osteopenia secondarily to decreased bone formation and enhanced bone resorption (18, 60) .
Inactivation of Rbpj in osteocytes did not result in a skeletal phenotype, and this is in agreement with prior observations following its inactivation in cells expressing a 2.3-kb fragment of the type I␣1 collagen promoter (48) . These findings indicate that Rbpj is dispensable for the function of mature osteoblasts and osteocytes. The reason for this is not entirely clear, but Rbpj under basal conditions is an inhibitor of gene transcription, suggesting that this function is not essential for osteoblast/osteocyte maturation or activity. In contrast, inactivation of Notch1 and Notch2 in osteocytes causes an increase in cancellous bone secondary to an increase in osteoblast number, suggesting that these effects of Notch1 and Notch2 do not overlap with those of Rbpj and are independent of Rbpj-mediated signaling (6) . If this is the case, Notch noncanonical signaling may play an undiscovered role in osteocyte function, but under conditions of pronounced Notch activation, as occurring in the Rosa Notch mouse model, canonical signaling prevails. It is also possible that the deletion of Notch1 and -2 by the Dmp1-driven Cre recombinase was more efficient than the deletion of Rbpj, since Rbpj mRNA levels in bone extracts were suppressed by 20 -45%. Whereas noncanonical signals can mediate Notch actions, their role is poorly understood, and this pathway has not been characterized in cells of the osteoblastic lineage, adding difficulties to the interpretation of the discrepant results between the deletion of Notch1 and -2 and of Rbpj in osteocytes. Deltex is known to mediate noncanonical signals of Notch, and Deltex2 and -3 are expressed by cells of the osteoblastic lineage, and their selective deletion in osteocytes may help clarify their function and the role of noncanonical Notch signaling in these cells (14) .
In contrast to the lack of an Rbpj function under basal conditions, Rbpj inactivation reversed the phenotype observed following Notch activation. This is in accord with the reversal of the osteosclerotic phenotype by the Rbpj inactivation following Notch1 activation in type I collagen-expressing cells (48) . Similarly, the effects of the Notch1 activation on limb development are Rbpj dependent, whereas the effects of Notch1 on committed chondrocytes are both Rbpj dependent and independent (10, 28).
A limitation of the present work is that the expression of Dmp1, used to direct Cre and activate Notch, is not circumscribed to osteocytes, and Dmp1 is also expressed by other cells of the same lineage, including terminally mature osteoblasts (26, 56) . However, activation of Notch1 in osteocytes results in a unique osteosclerotic phenotype, suggesting that the impact of Dmp1-directed Notch activation occurred primarily in these cells. The Rosa Notch model allows for the preferential activation of Notch in osteocytes. However, osteocytes contact neighboring cells through gap junctions that form on the tips of their dendritic processes (11) . As a consequence, classic Notch activation by Notchligand interactions in neighboring cells might not occur (29, 58) . Notch activation in osteocytes could occur in response to mechanical forces, as it has been reported for Wnt signal activation (27) . Indeed, Notch signaling is activated by fluid shear stress in the osteocytic cell line MLO-Y4 (S. Zanotti and E. Canalis, unpublished observations). Another possible way of Notch activation in osteocytes might be in response to Wnt signaling, which has been shown to activate the Notch pathway in these cells (51) .
In conclusion, the activation of Notch1 in osteocytes causes osteopetrosis by inducing Notch canonical signaling, which downregulates Sost and Dkk1 and upregulates osteoprotegerin expression.
